Centro Investigación del Cáncer James Lind ( Site 0064)

Temuco, Araucania 4800827

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Hepatocellular

Studies at this site

• Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) — Completed